Cargando…
Measuring the indirect cost associated with advanced non-small cell lung cancer: a nationwide cross-sectional study in China
PURPOSE: This study was conducted to estimate the indirect cost of locally advanced and metastatic non-small cell lung cancer (NSCLC) without sensitizing EGFR and ALK alterations in China and explore the predictors from both patient and caregiver perspectives. METHODS: Data were obtained from a nati...
Autores principales: | Yang, Yi, Xia, Yu, Su, Chunxia, Chen, Jia, Long, Enwu, Zhang, Haibo, Gan, Yuying, Yan, Fei, Chen, Yingyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349708/ https://www.ncbi.nlm.nih.gov/pubmed/36056953 http://dx.doi.org/10.1007/s00432-022-04258-w |
Ejemplares similares
-
Measuring direct non-medical burden among patients with advanced non-small cell lung cancer in China: is there a difference in health status?
por: Xia, Yu, et al.
Publicado: (2023) -
A Study of Patient Preferences for the Treatment of Non–small Cell Lung Cancer in Western China: A Discrete-Choice Experiment
por: Liu, Fei, et al.
Publicado: (2021) -
Indirect costs of rheumatoid arthritis
por: Raciborski, Filip, et al.
Publicado: (2015) -
Indirect comparison between immunotherapy alone and immunotherapy plus chemotherapy as first-line treatment for advanced non-small cell lung cancer: a systematic review
por: Li, Lingling, et al.
Publicado: (2020) -
Direct and indirect costs of allergic and non‐allergic rhinitis to adults in Beijing, China
por: Li, Xian, et al.
Publicado: (2022)